Literature DB >> 35292587

Prevalence of HTLV-I Infection and Its Association with Tuberculosis among Patients at an Urban Clinic in Haiti.

Kathleen F Walsh1,2, Myung Hee Lee1, Josef A Brejt2, Mary J Reust1, Marc Jean Juste3, Genevieve Hilaire3, Jean William Pape1,4,3, Serena Koenig5, Kathryn Dupnik1,4.   

Abstract

This retrospective case-control study examined the prevalence of HTLV-I and its association with tuberculosis among urban clinic patients in Haiti. Prevalence of HTLV-I among tuberculosis cases was 2.1% and among controls was 2.4%. Prevalence of HLTV-I was higher in females than males (odds ratio [OR] 2.45, P = 0.020). HTLV-I prevalence in those ≥ 50 years was 8.4% compared with 1.3% in those < 50 (OR 6.74, P < 0.001). We found no association between HTLV-I and tuberculosis in this population.

Entities:  

Year:  2022        PMID: 35292587      PMCID: PMC9128705          DOI: 10.4269/ajtmh.21-0702

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  18 in total

Review 1.  Global epidemiology of HTLV-I infection and associated diseases.

Authors:  Fernando A Proietti; Anna Bárbara F Carneiro-Proietti; Bernadette C Catalan-Soares; Edward L Murphy
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  Tuberculosis and human T-cell lymphotropic virus type 1 infection.

Authors:  R A Seaton
Journal:  Clin Infect Dis       Date:  1997-05       Impact factor: 9.079

Review 3.  Immunology of Mycobacterium tuberculosis Infections.

Authors:  Jonathan Kevin Sia; Jyothi Rengarajan
Journal:  Microbiol Spectr       Date:  2019-07

Review 4.  T cells and adaptive immunity to Mycobacterium tuberculosis in humans.

Authors:  Luke D Jasenosky; Thomas J Scriba; Willem A Hanekom; Anne E Goldfeld
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

Review 5.  Infection with human retroviruses other than HIV-1: HIV-2, HTLV-1, HTLV-2, HTLV-3 and HTLV-4.

Authors:  David Nicolás; Juan Ambrosioni; Roger Paredes; M Ángeles Marcos; Christian Manzardo; Asunción Moreno; José M Miró
Journal:  Expert Rev Anti Infect Ther       Date:  2015-06-25       Impact factor: 5.091

6.  Antibody to HIV-1, HTLV-I, and HCV in three populations of rural Haitians.

Authors:  J P Allain; W Hodges; M H Einstein; J Geisler; C Neilly; S Delaney; B Hodges; H Lee
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992-12

7.  Age and gender specific prevalence of HTLV-1.

Authors:  Nobuoki Eshima; Osuke Iwata; Sachiko Iwata; Minoru Tabata; Yasunori Higuchi; Toyojiro Matsuishi; Shigeru Karukaya
Journal:  J Clin Virol       Date:  2009-04-21       Impact factor: 3.168

8.  Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis.

Authors:  Hans R Norrgren; Sana Bamba; Olav Larsen; Zacarias Da Silva; Peter Aaby; Tuija Koivula; Sören Andersson
Journal:  J Acquir Immune Defic Syndr       Date:  2008-08-15       Impact factor: 3.731

9.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

Review 10.  HTLV-1 and innate immunity.

Authors:  Chloé Journo; Renaud Mahieux
Journal:  Viruses       Date:  2011-08-08       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.